Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market By Product Type( Stent , PTA Balloon Catheter) By Diagnosis/Imaging Techniques(High-definition MRI, Balloon test occlusion, Computed tomographic angiogram (CTA), Transcranial Doppler ultrasound (TCD), Digital subtraction angiography (DSA), Others) By End Users( Hospitals, Clinics, Diagnostic Centres, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030

Report ID :AMI-1118 | Category : Healthcare | Published Date : April, 2022 | Pages : 402 | Format :PDF

Industry Trends

In the last few years, due to the sedentary lifestyle and urbanization a huge population is suffering from cerebrovascular diseases. Intracranial Atherosclerotic Disease (ICAD) is one amongst the prelevant disease wherein blockage, malformation, or hemorrhage prevents the brain cells from getting enough oxygen leading to brain damage. When plaque (cholesterol, fatty deposits, and other substances) builds up in the blood vessels at the base of the brain, it narrows and hardens, creating intracranial atherosclerotic disease. This condition is also mentioned to as atherosclerosis, stenosis or toughening of the arteries. A stroke can occur when an artery narrows to the point that blood flow to the brain is restricted. Strokes can be caused by blood clots or bleeding (haemorrhage), which deprives brain cells of oxygen and causes them to die. Stroke is believed to be due to intracranial atherosclerotic disease, which is the most prevalent cause of stroke globally. In the last few years, diagnostic and treatment options for intracranial atherosclerotic disease (ICAD) have risen. In the implementation of precision medicine for ICAD, concrete initiatives have evolved, centering individualised treatment for the prevention of stroke and cognitive impairment around pathology. Additionally the diagnosis for intracranial atherosclerotic disease is very critical which has gained huge importance for the scope of treatment. Various high technology based diagnosis techniques such as high definition MRI can detect vessel wall lesions, both stenotic and nonstenotic. Recent imaging technologies, such as optical coherence tomography and other modalities, are reviewed to screen the intracranial arteries for symptomatic ICAD, not only to diagnose ICAD, but also to establish if ICAD plaques have any high-risk traits that should be treated. Potential future developments for the treatment of ICAD such as new iterations of self-expanding intracranial stents with better delivery systems, and the development of trackable drug-coated balloons for the cerebral circulation to treat primary stages of ICAD has led to a tremendous growth in the global intracranial atherosclerotic disease (ICAD) pathology market globally.

In terms of revenue, global intracranial atherosclerotic disease (ICAD) pathology market is growing at a CAGR of 5.62% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.

Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue & Forecast, (US$ Million), 2015 – 2030

Product Type Outlook:

Based on the type, the global intracranial atherosclerotic disease (ICAD) pathology market is segmented into stent and PTA Balloon Catheter. Intracranial stents are small mesh tubes that are permanently implanted in the brain to unblock clogged arteries and enhance blood flow. Over the last decade, endovascular revascularization of damaged intracranial arteries using stents has grown popular as a way to improve the poor outcomes associated with symptomatic ICAD. Stenting is sometimes done in conjunction with balloon angioplasty to prevent plaque recoiling and to cover a plaque or an intimal flap. It may also help to prevent vascular dissection. The first intracranial stenting stent was a balloon-expandable stent that performed well in the SSYLVIA clinical study (Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries), but it was never manufactured or marketed. Later on the Wingspan stent was the first self-expanding stent designed exclusively for symptomatic ICAD treatment. It is currently the only stent approved by the Food and Drug Administration (FDA) for the treatment of symptomatic intracranial ICAD. According to the American Heart Association (AHA) it was studied that the stent appeared to cut risk to 50 percent and lower the risk of recurrent stroke or death in the patients.

Diagnosis/Imaging Techniques Outlook:

Based on diagnosis/imaging techniques, the intracranial atherosclerotic disease (ICAD) pathology market is segmented into high-definition MRI, balloon test occlusion, computed tomographic angiogram (CTA), transcranial doppler ultrasound (TCD), digital subtraction angiography (DSA) and others. CT (computerized tomography) angiography has gradually replaced invasive traditional angiography as the main technique for diagnosing and characterisation of most neurovascular disorders. A specific dye is injected into the patient's circulation, allowing the doctor to view blood flow on a CT scan, which is known as a computed tomographic angiography (CTA). Over the last few years, there have been advanced technologies that are being incorporated into diagnosis techniques to have precision results for better treatment for intracranial atherosclerotic disease (ICAD). Moreover hospitals and diagnostic centers are looking forward to invest in advanced diagnosis techniques such as 3-D imaging with rotational angiography which uses a quick spin around the patient to create a computed tomography (CT). Thus with such advancements in the diagnosis and imaging techniques the global intracranial atherosclerotic disease (ICAD) pathology market is experiencing tremendous growth.

Region Outlook:

Based on the regions, North America had the highest share in the intracranial atherosclerotic disease (ICAD) pathology market in the year 2021. Stroke is one amongst the prominent causes of death and morbidity in the United States. Large artery atherosclerosis causes almost 20% of ischemic strokes, with over half of those occurring intracranially, and it has a high recurrence rate despite medical treatment. In the last few years there have been technological advancements and huge investments in the diagnosis and medical treatment for intracranial atherosclerotic disease in United States and Canada. Moreover the presence of key players including Boston Scientific Corporation and others are contributing to the advancements and innovations in the products and equipment required for imaging and diagnosis of intracranial atherosclerotic disease. Furthermore, there has been rise in the research and development for the treatment technologies of ICAD which has led to the growth in intracranial atherosclerotic disease (ICAD) pathology market.

Competitive Landscape

The report provides both, qualitative and quantitative research of global intracranial atherosclerotic disease (ICAD) pathology market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.

Some of the players operating in the global intracranial atherosclerotic disease (ICAD) pathology market are listed below:

Acandis GmbH
BALT group.
Boston Scientific Corporation
CERENOVUS
Medtronic
MicroPort Scientific Corporation
Stryker
Terumo Corporation
Other Market Participants

Click on image to enlarge

Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market:

By Product Type

Stent
PTA Balloon Catheter

By Diagnosis/imaging techniques

High-definition MRI
Balloon test occlusion
Computed tomographic angiogram (CTA)
Transcranial Doppler ultrasound (TCD)
Digital subtraction angiography (DSA)
Others

By End Users

Hospitals
Clinics
Diagnostic centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
  - Denmark
  - Finland
  - Iceland
  - Sweden
  - Norway
- Benelux Union
  - Belgium
  - The Netherlands
  - Luxembourg
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
  - Indonesia
  - Thailand
  - Malaysia
  - Singapore
  - Rest of Southeast Asia
- Rest of Asia Pacific
Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America

Table of Contents

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2021

1.2.2. Base Year: 2021

1.2.3. Forecast Years: 2022 – 2030

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from AMI’s Perspective**

5. Holistic Overview of Intracranial Atherosclerotic Disease (ICAD) Pathology Market

6. Market Synopsis: Intracranial Atherosclerotic Disease (ICAD) Pathology Market

7. Intracranial Atherosclerotic Disease (ICAD) Pathology Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.2.4. Challenges

7.3. Trends in Intracranial Atherosclerotic Disease (ICAD) Pathology Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Intracranial Atherosclerotic Disease (ICAD) Pathology Market

7.6. Porter’s Five Force Analysis

7.7. Impact of Covid-19 on Intracranial Atherosclerotic Disease (ICAD) Pathology Market

8. Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 – 2030

8.1. Overview

8.1.1. Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn)

8.2. Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

8.2.1. Stent

8.2.1.1. Definition

8.2.1.2. Market Estimation and Penetration, 2015 - 2021

8.2.1.3. Market Forecast, 2022 - 2030

8.2.1.4. Compound Annual Growth Rate (CAGR)

8.2.1.5. Regional Bifurcation

8.2.1.5.1. North America

8.2.1.5.1.1. Market Estimation, 2015 - 2021

8.2.1.5.1.2. Market Forecast, 2022 - 2030

8.2.1.5.2. Europe

8.2.1.5.2.1. Market Estimation, 2015 - 2021

8.2.1.5.2.2. Market Forecast, 2022 - 2030

8.2.1.5.3. Asia Pacific

8.2.1.5.3.1. Market Estimation, 2015 - 2021

8.2.1.5.3.2. Market Forecast, 2022 - 2030

8.2.1.5.4. Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2015 - 2021

8.2.1.5.4.2. Market Forecast, 2022 - 2030

8.2.1.5.5. Latin America

8.2.1.5.5.1. Market Estimation, 2015 - 2021

8.2.1.5.5.2. Market Forecast, 2022 - 2030

8.2.2. PTA Balloon Catheter

8.2.2.1. Definition

8.2.2.2. Market Estimation and Penetration, 2015 - 2021

8.2.2.3. Market Forecast, 2022 - 2030

8.2.2.4. Compound Annual Growth Rate (CAGR)

8.2.2.5. Regional Bifurcation

8.2.2.5.1. North America

8.2.2.5.1.1. Market Estimation, 2015 - 2021

8.2.2.5.1.2. Market Forecast, 2022 - 2030

8.2.2.5.2. Europe

8.2.2.5.2.1. Market Estimation, 2015 - 2021

8.2.2.5.2.2. Market Forecast, 2022 - 2030

8.2.2.5.3. Asia Pacific

8.2.2.5.3.1. Market Estimation, 2015 - 2021

8.2.2.5.3.2. Market Forecast, 2022 - 2030

8.2.2.5.4. Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2015 - 2021

8.2.2.5.4.2. Market Forecast, 2022 - 2030

8.2.2.5.5. Latin America

8.2.2.5.5.1. Market Estimation, 2015 - 2021

8.2.2.5.5.2. Market Forecast, 2022 - 2030

8.3. Key Segment for Channeling Investments

8.3.1. By Product Type

9. Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 – 2030

9.1. Overview

9.2. Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

9.2.1. High Definition MRI

9.2.1.1. Definition

9.2.1.2. Market Estimation and Penetration, 2015 - 2021

9.2.1.3. Market Forecast, 2022 - 2030

9.2.1.4. Compound Annual Growth Rate (CAGR)

9.2.1.5. Regional Bifurcation

9.2.1.5.1. North America

9.2.1.5.1.1. Market Estimation, 2015 - 2021

9.2.1.5.1.2. Market Forecast, 2022 - 2030

9.2.1.5.2. Europe

9.2.1.5.2.1. Market Estimation, 2015 - 2021

9.2.1.5.2.2. Market Forecast, 2022 - 2030

9.2.1.5.3. Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 - 2021

9.2.1.5.3.2. Market Forecast, 2022 - 2030

9.2.1.5.4. Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 - 2021

9.2.1.5.4.2. Market Forecast, 2022 - 2030

9.2.1.5.5. Latin America

9.2.1.5.5.1. Market Estimation, 2015 - 2021

9.2.1.5.5.2. Market Forecast, 2022 - 2030

9.2.2. Balloon test occlusion

9.2.2.1. Definition

9.2.2.2. Market Estimation and Penetration, 2015 - 2021

9.2.2.3. Market Forecast, 2022 - 2030

9.2.2.4. Compound Annual Growth Rate (CAGR)

9.2.2.5. Regional Bifurcation

9.2.2.5.1. North America

9.2.2.5.1.1. Market Estimation, 2015 - 2021

9.2.2.5.1.2. Market Forecast, 2022 - 2030

9.2.2.5.2. Europe

9.2.2.5.2.1. Market Estimation, 2015 - 2021

9.2.2.5.2.2. Market Forecast, 2022 - 2030

9.2.2.5.3. Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 - 2021

9.2.2.5.3.2. Market Forecast, 2022 - 2030

9.2.2.5.4. Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 - 2021

9.2.2.5.4.2. Market Forecast, 2022 - 2030

9.2.2.5.5. Latin America

9.2.2.5.5.1. Market Estimation, 2015 - 2021

9.2.2.5.5.2. Market Forecast, 2022 - 2030

9.2.3. Computed tomographic angiogram (CTA)

9.2.3.1. Definition

9.2.3.2. Market Estimation and Penetration, 2015 - 2021

9.2.3.3. Market Forecast, 2022 - 2030

9.2.3.4. Compound Annual Growth Rate (CAGR)

9.2.3.5. Regional Bifurcation

9.2.3.5.1. North America

9.2.3.5.1.1. Market Estimation, 2015 - 2021

9.2.3.5.1.2. Market Forecast, 2022 - 2030

9.2.3.5.2. Europe

9.2.3.5.2.1. Market Estimation, 2015 - 2021

9.2.3.5.2.2. Market Forecast, 2022 - 2030

9.2.3.5.3. Asia Pacific

9.2.3.5.3.1. Market Estimation, 2015 - 2021

9.2.3.5.3.2. Market Forecast, 2022 - 2030

9.2.3.5.4. Middle East and Africa

9.2.3.5.4.1. Market Estimation, 2015 - 2021

9.2.3.5.4.2. Market Forecast, 2022 - 2030

9.2.3.5.5. Latin America

9.2.3.5.5.1. Market Estimation, 2015 - 2021

9.2.3.5.5.2. Market Forecast, 2022 - 2030

9.2.4. Transcranial Doppler ultrasound (TCD)

9.2.4.1. Definition

9.2.4.2. Market Estimation and Penetration, 2015 - 2021

9.2.4.3. Market Forecast, 2022 - 2030

9.2.4.4. Compound Annual Growth Rate (CAGR)

9.2.4.5. Regional Bifurcation

9.2.4.5.1. North America

9.2.4.5.1.1. Market Estimation, 2015 - 2021

9.2.4.5.1.2. Market Forecast, 2022 - 2030

9.2.4.5.2. Europe

9.2.4.5.2.1. Market Estimation, 2015 - 2021

9.2.4.5.2.2. Market Forecast, 2022 - 2030

9.2.4.5.3. Asia Pacific

9.2.4.5.3.1. Market Estimation, 2015 - 2021

9.2.4.5.3.2. Market Forecast, 2022 - 2030

9.2.4.5.4. Middle East and Africa

9.2.4.5.4.1. Market Estimation, 2015 - 2021

9.2.4.5.4.2. Market Forecast, 2022 - 2030

9.2.4.5.5. Latin America

9.2.4.5.5.1. Market Estimation, 2015 - 2021

9.2.4.5.5.2. Market Forecast, 2022 - 2030

9.2.5. Digital subtraction angiography (DSA)

9.2.5.1. Definition

9.2.5.2. Market Estimation and Penetration, 2015 - 2021

9.2.5.3. Market Forecast, 2022 - 2030

9.2.5.4. Compound Annual Growth Rate (CAGR)

9.2.5.5. Regional Bifurcation

9.2.5.5.1. North America

9.2.5.5.1.1. Market Estimation, 2015 - 2021

9.2.5.5.1.2. Market Forecast, 2022 - 2030

9.2.5.5.2. Europe

9.2.5.5.2.1. Market Estimation, 2015 - 2021

9.2.5.5.2.2. Market Forecast, 2022 - 2030

9.2.5.5.3. Asia Pacific

9.2.5.5.3.1. Market Estimation, 2015 - 2021

9.2.5.5.3.2. Market Forecast, 2022 - 2030

9.2.5.5.4. Middle East and Africa

9.2.5.5.4.1. Market Estimation, 2015 - 2021

9.2.5.5.4.2. Market Forecast, 2022 - 2030

9.2.5.5.5. Latin America

9.2.5.5.5.1. Market Estimation, 2015 - 2021

9.2.5.5.5.2. Market Forecast, 2022 - 2030

9.2.6. Others

9.2.6.1. Definition

9.2.6.2. Market Estimation and Penetration, 2015 - 2021

9.2.6.3. Market Forecast, 2022 - 2030

9.2.6.4. Compound Annual Growth Rate (CAGR)

9.2.6.5. Regional Bifurcation

9.2.6.5.1. North America

9.2.6.5.1.1. Market Estimation, 2015 - 2021

9.2.6.5.1.2. Market Forecast, 2022 - 2030

9.2.6.5.2. Europe

9.2.6.5.2.1. Market Estimation, 2015 - 2021

9.2.6.5.2.2. Market Forecast, 2022 - 2030

9.2.6.5.3. Asia Pacific

9.2.6.5.3.1. Market Estimation, 2015 - 2021

9.2.6.5.3.2. Market Forecast, 2022 - 2030

9.2.6.5.4. Middle East and Africa

9.2.6.5.4.1. Market Estimation, 2015 - 2021

9.2.6.5.4.2. Market Forecast, 2022 - 2030

9.2.6.5.5. Latin America

9.2.6.5.5.1. Market Estimation, 2015 - 2021

9.2.6.5.5.2. Market Forecast, 2022 - 2030

9.3. Key Segment for Channeling Investments

9.3.1. By Diagnosis/imaging techniques

10. Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 – 2030

10.1. Overview

10.2. Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

10.2.1. Hospitals

10.2.1.1. Definition

10.2.1.2. Market Estimation and Penetration, 2015 - 2021

10.2.1.3. Market Forecast, 2022 - 2030

10.2.1.4. Compound Annual Growth Rate (CAGR)

10.2.1.5. Regional Bifurcation

10.2.1.5.1. North America

10.2.1.5.1.1. Market Estimation, 2015 - 2021

10.2.1.5.1.2. Market Forecast, 2022 - 2030

10.2.1.5.2. Europe

10.2.1.5.2.1. Market Estimation, 2015 - 2021

10.2.1.5.2.2. Market Forecast, 2022 - 2030

10.2.1.5.3. Asia Pacific

10.2.1.5.3.1. Market Estimation, 2015 - 2021

10.2.1.5.3.2. Market Forecast, 2022 - 2030

10.2.1.5.4. Middle East and Africa

10.2.1.5.4.1. Market Estimation, 2015 - 2021

10.2.1.5.4.2. Market Forecast, 2022 - 2030

10.2.1.5.5. Latin America

10.2.1.5.5.1. Market Estimation, 2015 - 2021

10.2.1.5.5.2. Market Forecast, 2022 - 2030

10.2.2. Clinics

10.2.2.1. Definition

10.2.2.2. Market Estimation and Penetration, 2015 - 2021

10.2.2.3. Market Forecast, 2022 - 2030

10.2.2.4. Compound Annual Growth Rate (CAGR)

10.2.2.5. Regional Bifurcation

10.2.2.5.1. North America

10.2.2.5.1.1. Market Estimation, 2015 - 2021

10.2.2.5.1.2. Market Forecast, 2022 - 2030

10.2.2.5.2. Europe

10.2.2.5.2.1. Market Estimation, 2015 - 2021

10.2.2.5.2.2. Market Forecast, 2022 - 2030

10.2.2.5.3. Asia Pacific

10.2.2.5.3.1. Market Estimation, 2015 - 2021

10.2.2.5.3.2. Market Forecast, 2022 - 2030

10.2.2.5.4. Middle East and Africa

10.2.2.5.4.1. Market Estimation, 2015 - 2021

10.2.2.5.4.2. Market Forecast, 2022 - 2030

10.2.2.5.5. Latin America

10.2.2.5.5.1. Market Estimation, 2015 - 2021

10.2.2.5.5.2. Market Forecast, 2022 - 2030

10.2.3. Diagnostic centers

10.2.3.1. Definition

10.2.3.2. Market Estimation and Penetration, 2015 - 2021

10.2.3.3. Market Forecast, 2022 - 2030

10.2.3.4. Compound Annual Growth Rate (CAGR)

10.2.3.5. Regional Bifurcation

10.2.3.5.1. North America

10.2.3.5.1.1. Market Estimation, 2015 - 2021

10.2.3.5.1.2. Market Forecast, 2022 - 2030

10.2.3.5.2. Europe

10.2.3.5.2.1. Market Estimation, 2015 - 2021

10.2.3.5.2.2. Market Forecast, 2022 - 2030

10.2.3.5.3. Asia Pacific

10.2.3.5.3.1. Market Estimation, 2015 - 2021

10.2.3.5.3.2. Market Forecast, 2022 - 2030

10.2.3.5.4. Middle East and Africa

10.2.3.5.4.1. Market Estimation, 2015 - 2021

10.2.3.5.4.2. Market Forecast, 2022 - 2030

10.2.3.5.5. Latin America

10.2.3.5.5.1. Market Estimation, 2015 - 2021

10.2.3.5.5.2. Market Forecast, 2022 - 2030

10.2.4. Others

10.2.4.1. Definition

10.2.4.2. Market Estimation and Penetration, 2015 - 2021

10.2.4.3. Market Forecast, 2022 - 2030

10.2.4.4. Compound Annual Growth Rate (CAGR)

10.2.4.5. Regional Bifurcation

10.2.4.5.1. North America

10.2.4.5.1.1. Market Estimation, 2015 - 2021

10.2.4.5.1.2. Market Forecast, 2022 - 2030

10.2.4.5.2. Europe

10.2.4.5.2.1. Market Estimation, 2015 - 2021

10.2.4.5.2.2. Market Forecast, 2022 - 2030

10.2.4.5.3. Asia Pacific

10.2.4.5.3.1. Market Estimation, 2015 - 2021

10.2.4.5.3.2. Market Forecast, 2022 - 2030

10.2.4.5.4. Middle East and Africa

10.2.4.5.4.1. Market Estimation, 2015 - 2021

10.2.4.5.4.2. Market Forecast, 2022 - 2030

10.2.4.5.5. Latin America

10.2.4.5.5.1. Market Estimation, 2015 - 2021

10.2.4.5.5.2. Market Forecast, 2022 - 2030

10.3. Key Segment for Channeling Investments

10.3.1. By End Users

11. North America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 - 2030

11.1. Overview

11.1.1. North America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn)

11.2. North America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

11.2.1. Stent

11.2.2. PTA Balloon Catheter

11.3. North America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

11.3.1. High Definition MRI

11.3.2. Balloon test occlusion

11.3.3. Computed tomographic angiogram (CTA)

11.3.4. Transcranial Doppler ultrasound (TCD)

11.3.5. Digital subtraction angiography (DSA)

11.3.6. Others

11.4. North America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

11.4.1. Hospitals

11.4.2. Clinics

11.4.3. Diagnostic centers

11.4.4. Others

11.5. North America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country

11.5.1. U.S

11.5.1.1. U.S Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

11.5.1.1.1. Stent

11.5.1.1.2. PTA Balloon Catheter

11.5.1.2. U.S Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

11.5.1.2.1. High Definition MRI

11.5.1.2.2. Balloon test occlusion

11.5.1.2.3. Computed tomographic angiogram (CTA)

11.5.1.2.4. Transcranial Doppler ultrasound (TCD)

11.5.1.2.5. Digital subtraction angiography (DSA)

11.5.1.2.6. Others

11.5.1.3. U.S Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

11.5.1.3.1. Hospitals

11.5.1.3.2. Clinics

11.5.1.3.3. Diagnostic centers

11.5.1.3.4. Others

11.5.2. Canada

11.5.2.1. Canada Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

11.5.2.1.1. Stent

11.5.2.1.2. PTA Balloon Catheter

11.5.2.2. Canada Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

11.5.2.2.1. High Definition MRI

11.5.2.2.2. Balloon test occlusion

11.5.2.2.3. Computed tomographic angiogram (CTA)

11.5.2.2.4. Transcranial Doppler ultrasound (TCD)

11.5.2.2.5. Digital subtraction angiography (DSA)

11.5.2.2.6. Others

11.5.2.3. Canada Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

11.5.2.3.1. Hospitals

11.5.2.3.2. Clinics

11.5.2.3.3. Diagnostic centers

11.5.2.3.4. Others

11.5.3. Mexico

11.5.3.1. Mexico Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

11.5.3.1.1. Stent

11.5.3.1.2. PTA Balloon Catheter

11.5.3.2. Mexico Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

11.5.3.2.1. High Definition MRI

11.5.3.2.2. Balloon test occlusion

11.5.3.2.3. Computed tomographic angiogram (CTA)

11.5.3.2.4. Transcranial Doppler ultrasound (TCD)

11.5.3.2.5. Digital subtraction angiography (DSA)

11.5.3.2.6. Others

11.5.3.3. Mexico Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

11.5.3.3.1. Hospitals

11.5.3.3.2. Clinics

11.5.3.3.3. Diagnostic centers

11.5.3.3.4. Others

11.5.4. Rest of North America

11.5.4.1. Rest of North America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

11.5.4.1.1. Stent

11.5.4.1.2. PTA Balloon Catheter

11.5.4.2. Rest of North America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

11.5.4.2.1. High Definition MRI

11.5.4.2.2. Balloon test occlusion

11.5.4.2.3. Computed tomographic angiogram (CTA)

11.5.4.2.4. Transcranial Doppler ultrasound (TCD)

11.5.4.2.5. Digital subtraction angiography (DSA)

11.5.4.2.6. Others

11.5.4.3. Rest of North America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

11.5.4.3.1. Hospitals

11.5.4.3.2. Clinics

11.5.4.3.3. Diagnostic centers

11.5.4.3.4. Others

11.6. Key Segment for Channeling Investments

11.6.1. By Country

11.6.2. By Product Type

11.6.3. By Diagnosis/imaging techniques

11.6.4. By End Users

12. Europe Intracranial Atherosclerotic Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 - 2030

12.1. Overview

12.1.1. Europe Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn)

12.2. Europe Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

12.2.1. Stent

12.2.2. PTA Balloon Catheter

12.3. Europe Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

12.3.1. High Definition MRI

12.3.2. Balloon test occlusion

12.3.3. Computed tomographic angiogram (CTA)

12.3.4. Transcranial Doppler ultrasound (TCD)

12.3.5. Digital subtraction angiography (DSA)

12.3.6. Others

12.4. Europe Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

12.4.1. Hospitals

12.4.2. Clinics

12.4.3. Diagnostic centers

12.4.4. Others

12.5. Europe Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country

12.5.1. France

12.5.1.1. France Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

12.5.1.1.1. Stent

12.5.1.1.2. PTA Balloon Catheter

12.5.1.2. France Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

12.5.1.2.1. High Definition MRI

12.5.1.2.2. Balloon test occlusion

12.5.1.2.3. Computed tomographic angiogram (CTA)

12.5.1.2.4. Transcranial Doppler ultrasound (TCD)

12.5.1.2.5. Digital subtraction angiography (DSA)

12.5.1.2.6. Others

12.5.1.3. France Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.1.3.1. Hospitals

12.5.1.3.2. Clinics

12.5.1.3.3. Diagnostic centers

12.5.1.3.4. Others

12.5.2. The UK

12.5.2.1. The UK Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

12.5.2.1.1. Stent

12.5.2.1.2. PTA Balloon Catheter

12.5.2.2. The UK Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

12.5.2.2.1. High Definition MRI

12.5.2.2.2. Balloon test occlusion

12.5.2.2.3. Computed tomographic angiogram (CTA)

12.5.2.2.4. Transcranial Doppler ultrasound (TCD)

12.5.2.2.5. Digital subtraction angiography (DSA)

12.5.2.2.6. Others

12.5.2.3. The UK Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.2.3.1. Hospitals

12.5.2.3.2. Clinics

12.5.2.3.3. Diagnostic centers

12.5.2.3.4. Others

12.5.3. Spain

12.5.3.1. Spain Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

12.5.3.1.1. Stent

12.5.3.1.2. PTA Balloon Catheter

12.5.3.2. Spain Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

12.5.3.2.1. High Definition MRI

12.5.3.2.2. Balloon test occlusion

12.5.3.2.3. Computed tomographic angiogram (CTA)

12.5.3.2.4. Transcranial Doppler ultrasound (TCD)

12.5.3.2.5. Digital subtraction angiography (DSA)

12.5.3.2.6. Others

12.5.3.3. Spain Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.3.3.1. Hospitals

12.5.3.3.2. Clinics

12.5.3.3.3. Diagnostic centers

12.5.3.3.4. Others

12.5.4. Germany

12.5.4.1. Germany Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

12.5.4.1.1. Stent

12.5.4.1.2. PTA Balloon Catheter

12.5.4.2. Germany Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

12.5.4.2.1. High Definition MRI

12.5.4.2.2. Balloon test occlusion

12.5.4.2.3. Computed tomographic angiogram (CTA)

12.5.4.2.4. Transcranial Doppler ultrasound (TCD)

12.5.4.2.5. Digital subtraction angiography (DSA)

12.5.4.2.6. Others

12.5.4.3. Germany Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.4.3.1. Hospitals

12.5.4.3.2. Clinics

12.5.4.3.3. Diagnostic centers

12.5.4.3.4. Others

12.5.5. Italy

12.5.5.1. Italy Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

12.5.5.1.1. Stent

12.5.5.1.2. PTA Balloon Catheter

12.5.5.2. Italy Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

12.5.5.2.1. High Definition MRI

12.5.5.2.2. Balloon test occlusion

12.5.5.2.3. Computed tomographic angiogram (CTA)

12.5.5.2.4. Transcranial Doppler ultrasound (TCD)

12.5.5.2.5. Digital subtraction angiography (DSA)

12.5.5.2.6. Others

12.5.5.3. Italy Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.5.3.1. Hospitals

12.5.5.3.2. Clinics

12.5.5.3.3. Diagnostic centers

12.5.5.3.4. Others

12.5.6. Nordic Countries

12.5.6.1. Nordic Countries Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

12.5.6.1.1. Stent

12.5.6.1.2. PTA Balloon Catheter

12.5.6.2. Nordic Countries Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

12.5.6.2.1. High Definition MRI

12.5.6.2.2. Balloon test occlusion

12.5.6.2.3. Computed tomographic angiogram (CTA)

12.5.6.2.4. Transcranial Doppler ultrasound (TCD)

12.5.6.2.5. Digital subtraction angiography (DSA)

12.5.6.2.6. Others

12.5.6.3. Nordic Countries Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.6.3.1. Hospitals

12.5.6.3.2. Clinics

12.5.6.3.3. Diagnostic centers

12.5.6.3.4. Others

12.5.6.4. Nordic Countries Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country

12.5.6.4.1. Denmark

12.5.6.4.2. Finland

12.5.6.4.3. Iceland

12.5.6.4.4. Sweden

12.5.6.4.5. Norway

12.5.7. Benelux Union

12.5.7.1. Benelux Union Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

12.5.7.1.1. Stent

12.5.7.1.2. PTA Balloon Catheter

12.5.7.2. Benelux Union Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

12.5.7.2.1. High Definition MRI

12.5.7.2.2. Balloon test occlusion

12.5.7.2.3. Computed tomographic angiogram (CTA)

12.5.7.2.4. Transcranial Doppler ultrasound (TCD)

12.5.7.2.5. Digital subtraction angiography (DSA)

12.5.7.2.6. Others

12.5.7.3. Benelux Union Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.7.3.1. Hospitals

12.5.7.3.2. Clinics

12.5.7.3.3. Diagnostic centers

12.5.7.3.4. Others

12.5.7.4. Benelux Union Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country

12.5.7.4.1. Belgium

12.5.7.4.2. The Netherlands

12.5.7.4.3. Luxembourg

12.5.8. Rest of Europe

12.5.8.1. Rest of Europe Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

12.5.8.1.1. Stent

12.5.8.1.2. PTA Balloon Catheter

12.5.8.2. Rest of Europe Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

12.5.8.2.1. High Definition MRI

12.5.8.2.2. Balloon test occlusion

12.5.8.2.3. Computed tomographic angiogram (CTA)

12.5.8.2.4. Transcranial Doppler ultrasound (TCD)

12.5.8.2.5. Digital subtraction angiography (DSA)

12.5.8.2.6. Others

12.5.8.3. Rest of Europe Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

12.5.8.3.1. Hospitals

12.5.8.3.2. Clinics

12.5.8.3.3. Diagnostic centers

12.5.8.3.4. Others

12.6. Key Segment for Channeling Investments

12.6.1. By Country

12.6.2. By Product Type

12.6.3. By Diagnosis/imaging techniques

12.6.4. By End Users

13. Asia Pacific Intracranial Atherosclerotic Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 - 2030

13.1. Overview

13.1.1. Asia Pacific Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn)

13.2. Asia Pacific Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

13.2.1. Stent

13.2.2. PTA Balloon Catheter

13.3. Asia Pacific Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

13.3.1. High Definition MRI

13.3.2. Balloon test occlusion

13.3.3. Computed tomographic angiogram (CTA)

13.3.4. Transcranial Doppler ultrasound (TCD)

13.3.5. Digital subtraction angiography (DSA)

13.3.6. Others

13.4. Asia Pacific Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

13.4.1. Hospitals

13.4.2. Clinics

13.4.3. Diagnostic centers

13.4.4. Others

13.5. Asia Pacific Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country

13.5.1. China

13.5.1.1. China Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

13.5.1.1.1. Stent

13.5.1.1.2. PTA Balloon Catheter

13.5.1.2. China Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

13.5.1.2.1. High Definition MRI

13.5.1.2.2. Balloon test occlusion

13.5.1.2.3. Computed tomographic angiogram (CTA)

13.5.1.2.4. Transcranial Doppler ultrasound (TCD)

13.5.1.2.5. Digital subtraction angiography (DSA)

13.5.1.2.6. Others

13.5.1.3. China Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.1.3.1. Hospitals

13.5.1.3.2. Clinics

13.5.1.3.3. Diagnostic centers

13.5.1.3.4. Others

13.5.2. Japan

13.5.2.1. Japan Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

13.5.2.1.1. Stent

13.5.2.1.2. PTA Balloon Catheter

13.5.2.2. Japan Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

13.5.2.2.1. High Definition MRI

13.5.2.2.2. Balloon test occlusion

13.5.2.2.3. Computed tomographic angiogram (CTA)

13.5.2.2.4. Transcranial Doppler ultrasound (TCD)

13.5.2.2.5. Digital subtraction angiography (DSA)

13.5.2.2.6. Others

13.5.2.3. Japan Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.2.3.1. Hospitals

13.5.2.3.2. Clinics

13.5.2.3.3. Diagnostic centers

13.5.2.3.4. Others

13.5.3. India

13.5.3.1. India Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

13.5.3.1.1. Stent

13.5.3.1.2. PTA Balloon Catheter

13.5.3.2. India Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

13.5.3.2.1. High Definition MRI

13.5.3.2.2. Balloon test occlusion

13.5.3.2.3. Computed tomographic angiogram (CTA)

13.5.3.2.4. Transcranial Doppler ultrasound (TCD)

13.5.3.2.5. Digital subtraction angiography (DSA)

13.5.3.2.6. Others

13.5.3.3. India Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.3.3.1. Hospitals

13.5.3.3.2. Clinics

13.5.3.3.3. Diagnostic centers

13.5.3.3.4. Others

13.5.4. New Zealand

13.5.4.1. New Zealand Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

13.5.4.1.1. Stent

13.5.4.1.2. PTA Balloon Catheter

13.5.4.2. New Zealand Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

13.5.4.2.1. High Definition MRI

13.5.4.2.2. Balloon test occlusion

13.5.4.2.3. Computed tomographic angiogram (CTA)

13.5.4.2.4. Transcranial Doppler ultrasound (TCD)

13.5.4.2.5. Digital subtraction angiography (DSA)

13.5.4.2.6. Others

13.5.4.3. New Zealand Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.4.3.1. Hospitals

13.5.4.3.2. Clinics

13.5.4.3.3. Diagnostic centers

13.5.4.3.4. Others

13.5.5. Australia

13.5.5.1. Australia Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

13.5.5.1.1. Stent

13.5.5.1.2. PTA Balloon Catheter

13.5.5.2. Australia Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

13.5.5.2.1. High Definition MRI

13.5.5.2.2. Balloon test occlusion

13.5.5.2.3. Computed tomographic angiogram (CTA)

13.5.5.2.4. Transcranial Doppler ultrasound (TCD)

13.5.5.2.5. Digital subtraction angiography (DSA)

13.5.5.2.6. Others

13.5.5.3. Australia Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.5.3.1. Hospitals

13.5.5.3.2. Clinics

13.5.5.3.3. Diagnostic centers

13.5.5.3.4. Others

13.5.6. South Korea

13.5.6.1. South Korea Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

13.5.6.1.1. Stent

13.5.6.1.2. PTA Balloon Catheter

13.5.6.2. South Korea Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

13.5.6.2.1. High Definition MRI

13.5.6.2.2. Balloon test occlusion

13.5.6.2.3. Computed tomographic angiogram (CTA)

13.5.6.2.4. Transcranial Doppler ultrasound (TCD)

13.5.6.2.5. Digital subtraction angiography (DSA)

13.5.6.2.6. Others

13.5.6.3. South Korea Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.6.3.1. Hospitals

13.5.6.3.2. Clinics

13.5.6.3.3. Diagnostic centers

13.5.6.3.4. Others

13.5.7. Southeast Asia

13.5.7.1. Southeast Asia Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

13.5.7.1.1. Stent

13.5.7.1.2. PTA Balloon Catheter

13.5.7.2. Southeast Asia Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

13.5.7.2.1. High Definition MRI

13.5.7.2.2. Balloon test occlusion

13.5.7.2.3. Computed tomographic angiogram (CTA)

13.5.7.2.4. Transcranial Doppler ultrasound (TCD)

13.5.7.2.5. Digital subtraction angiography (DSA)

13.5.7.2.6. Others

13.5.7.3. Southeast Asia Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.7.3.1. Hospitals

13.5.7.3.2. Clinics

13.5.7.3.3. Diagnostic centers

13.5.7.3.4. Others

13.5.7.4. Southeast Asia Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country

13.5.7.4.1. Indonesia

13.5.7.4.2. Thailand

13.5.7.4.3. Malaysia

13.5.7.4.4. Singapore

13.5.7.4.5. Rest of Southeast Asia

13.5.8. Rest of Asia Pacific

13.5.8.1. Rest of Asia Pacific Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

13.5.8.1.1. Stent

13.5.8.1.2. PTA Balloon Catheter

13.5.8.2. Rest of Asia Pacific Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

13.5.8.2.1. High Definition MRI

13.5.8.2.2. Balloon test occlusion

13.5.8.2.3. Computed tomographic angiogram (CTA)

13.5.8.2.4. Transcranial Doppler ultrasound (TCD)

13.5.8.2.5. Digital subtraction angiography (DSA)

13.5.8.2.6. Others

13.5.8.3. Rest of Asia Pacific Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

13.5.8.3.1. Hospitals

13.5.8.3.2. Clinics

13.5.8.3.3. Diagnostic centers

13.5.8.3.4. Others

13.6. Key Segment for Channeling Investments

13.6.1. By Country

13.6.2. By Product Type

13.6.3. By Diagnosis/imaging techniques

13.6.4. By End Users

14. Middle East and Africa Intracranial Atherosclerotic Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 - 2030

14.1. Overview

14.1.1. Middle East and Africa Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn)

14.2. Middle East and Africa Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

14.2.1. Stent

14.2.2. PTA Balloon Catheter

14.3. Middle East and Africa Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

14.3.1. High Definition MRI

14.3.2. Balloon test occlusion

14.3.3. Computed tomographic angiogram (CTA)

14.3.4. Transcranial Doppler ultrasound (TCD)

14.3.5. Digital subtraction angiography (DSA)

14.3.6. Others

14.4. Middle East and Africa Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

14.4.1. Hospitals

14.4.2. Clinics

14.4.3. Diagnostic centers

14.4.4. Others

14.5. Middle East and Africa Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country

14.5.1. Saudi Arabia

14.5.1.1. Saudi Arabia Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

14.5.1.1.1. Stent

14.5.1.1.2. PTA Balloon Catheter

14.5.1.2. Saudi Arabia Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

14.5.1.2.1. High Definition MRI

14.5.1.2.2. Balloon test occlusion

14.5.1.2.3. Computed tomographic angiogram (CTA)

14.5.1.2.4. Transcranial Doppler ultrasound (TCD)

14.5.1.2.5. Digital subtraction angiography (DSA)

14.5.1.2.6. Others

14.5.1.3. Saudi Arabia Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

14.5.1.3.1. Hospitals

14.5.1.3.2. Clinics

14.5.1.3.3. Diagnostic centers

14.5.1.3.4. Others

14.5.2. UAE

14.5.2.1. UAE Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

14.5.2.1.1. Stent

14.5.2.1.2. PTA Balloon Catheter

14.5.2.2. UAE Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

14.5.2.2.1. High Definition MRI

14.5.2.2.2. Balloon test occlusion

14.5.2.2.3. Computed tomographic angiogram (CTA)

14.5.2.2.4. Transcranial Doppler ultrasound (TCD)

14.5.2.2.5. Digital subtraction angiography (DSA)

14.5.2.2.6. Others

14.5.2.3. UAE Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

14.5.2.3.1. Hospitals

14.5.2.3.2. Clinics

14.5.2.3.3. Diagnostic centers

14.5.2.3.4. Others

14.5.3. Egypt

14.5.3.1. Egypt Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

14.5.3.1.1. Stent

14.5.3.1.2. PTA Balloon Catheter

14.5.3.2. Egypt Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

14.5.3.2.1. High Definition MRI

14.5.3.2.2. Balloon test occlusion

14.5.3.2.3. Computed tomographic angiogram (CTA)

14.5.3.2.4. Transcranial Doppler ultrasound (TCD)

14.5.3.2.5. Digital subtraction angiography (DSA)

14.5.3.2.6. Others

14.5.3.3. Egypt Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

14.5.3.3.1. Hospitals

14.5.3.3.2. Clinics

14.5.3.3.3. Diagnostic centers

14.5.3.3.4. Others

14.5.4. Kuwait

14.5.4.1. Kuwait Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

14.5.4.1.1. Stent

14.5.4.1.2. PTA Balloon Catheter

14.5.4.2. Kuwait Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

14.5.4.2.1. High Definition MRI

14.5.4.2.2. Balloon test occlusion

14.5.4.2.3. Computed tomographic angiogram (CTA)

14.5.4.2.4. Transcranial Doppler ultrasound (TCD)

14.5.4.2.5. Digital subtraction angiography (DSA)

14.5.4.2.6. Others

14.5.4.3. Kuwait Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

14.5.4.3.1. Hospitals

14.5.4.3.2. Clinics

14.5.4.3.3. Diagnostic centers

14.5.4.3.4. Others

14.5.5. South Africa

14.5.5.1. South Africa Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

14.5.5.1.1. Stent

14.5.5.1.2. PTA Balloon Catheter

14.5.5.2. South Africa Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

14.5.5.2.1. High Definition MRI

14.5.5.2.2. Balloon test occlusion

14.5.5.2.3. Computed tomographic angiogram (CTA)

14.5.5.2.4. Transcranial Doppler ultrasound (TCD)

14.5.5.2.5. Digital subtraction angiography (DSA)

14.5.5.2.6. Others

14.5.5.3. South Africa Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

14.5.5.3.1. Hospitals

14.5.5.3.2. Clinics

14.5.5.3.3. Diagnostic centers

14.5.5.3.4. Others

14.5.6. Rest of Middle East & Africa

14.5.6.1. Rest of Middle East & Africa Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

14.5.6.1.1. Stent

14.5.6.1.2. PTA Balloon Catheter

14.5.6.2. Rest of Middle East & Africa Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

14.5.6.2.1. High Definition MRI

14.5.6.2.2. Balloon test occlusion

14.5.6.2.3. Computed tomographic angiogram (CTA)

14.5.6.2.4. Transcranial Doppler ultrasound (TCD)

14.5.6.2.5. Digital subtraction angiography (DSA)

14.5.6.2.6. Others

14.5.6.3. Rest of Middle East & Africa Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

14.5.6.3.1. Hospitals

14.5.6.3.2. Clinics

14.5.6.3.3. Diagnostic centers

14.5.6.3.4. Others

14.6. Key Segment for Channeling Investments

14.6.1. By Country

14.6.2. By Product Type

14.6.3. By Diagnosis/imaging techniques

14.6.4. By End Users

15. Latin America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 - 2030

15.1. Overview

15.1.1. Latin America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn)

15.2. Latin America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

15.2.1. Stent

15.2.2. PTA Balloon Catheter

15.3. Latin America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

15.3.1. High Definition MRI

15.3.2. Balloon test occlusion

15.3.3. Computed tomographic angiogram (CTA)

15.3.4. Transcranial Doppler ultrasound (TCD)

15.3.5. Digital subtraction angiography (DSA)

15.3.6. Others

15.4. Latin America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

15.4.1. Hospitals

15.4.2. Clinics

15.4.3. Diagnostic centers

15.4.4. Others

15.5. Latin America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country

15.5.1. Brazil

15.5.1.1. Brazil Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

15.5.1.1.1. Stent

15.5.1.1.2. PTA Balloon Catheter

15.5.1.2. Brazil Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

15.5.1.2.1. High Definition MRI

15.5.1.2.2. Balloon test occlusion

15.5.1.2.3. Computed tomographic angiogram (CTA)

15.5.1.2.4. Transcranial Doppler ultrasound (TCD)

15.5.1.2.5. Digital subtraction angiography (DSA)

15.5.1.2.6. Others

15.5.1.3. Brazil Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

15.5.1.3.1. Hospitals

15.5.1.3.2. Clinics

15.5.1.3.3. Diagnostic centers

15.5.1.3.4. Others

15.5.2. Argentina

15.5.2.1. Argentina Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

15.5.2.1.1. Stent

15.5.2.1.2. PTA Balloon Catheter

15.5.2.2. Argentina Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

15.5.2.2.1. High Definition MRI

15.5.2.2.2. Balloon test occlusion

15.5.2.2.3. Computed tomographic angiogram (CTA)

15.5.2.2.4. Transcranial Doppler ultrasound (TCD)

15.5.2.2.5. Digital subtraction angiography (DSA)

15.5.2.2.6. Others

15.5.2.3. Argentina Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

15.5.2.3.1. Hospitals

15.5.2.3.2. Clinics

15.5.2.3.3. Diagnostic centers

15.5.2.3.4. Others

15.5.3. Rest of Latin America

15.5.3.1. Rest of Latin America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type

15.5.3.1.1. Stent

15.5.3.1.2. PTA Balloon Catheter

15.5.3.2. Rest of Latin America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques

15.5.3.2.1. High Definition MRI

15.5.3.2.2. Balloon test occlusion

15.5.3.2.3. Computed tomographic angiogram (CTA)

15.5.3.2.4. Transcranial Doppler ultrasound (TCD)

15.5.3.2.5. Digital subtraction angiography (DSA)

15.5.3.2.6. Others

15.5.3.3. Rest of Latin America Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users

15.5.3.3.1. Hospitals

15.5.3.3.2. Clinics

15.5.3.3.3. Diagnostic centers

15.5.3.3.4. Others

15.6. Key Segment for Channeling Investments

15.6.1. By Country

15.6.2. By Product Type

15.6.3. By Diagnosis/imaging techniques

15.6.4. By End Users

16. Competitive Benchmarking

16.1. Brand Benchmarking

16.2. Market Share Analysis, 2021

16.3. Global Presence and Growth Strategies

16.3.1. Mergers and Acquisitions

16.3.2. Product Launches

16.3.3. Investments Trends

16.3.4. R&D Initiatives

17. Player Profiles

17.1. Acandis GmbH

17.1.1. Company Details

17.1.2. Company Overview

17.1.3. Product Offerings

17.1.4. Key Developments

17.1.5. Financial Analysis

17.1.6. SWOT Analysis

17.1.7. Business Strategies

17.2. BALT group

17.2.1. Company Details

17.2.2. Company Overview

17.2.3. Product Offerings

17.2.4. Key Developments

17.2.5. Financial Analysis

17.2.6. SWOT Analysis

17.2.7. Business Strategies

17.3. Boston Scientific Corporation

17.3.1. Company Details

17.3.2. Company Overview

17.3.3. Product Offerings

17.3.4. Key Developments

17.3.5. Financial Analysis

17.3.6. SWOT Analysis

17.3.7. Business Strategies

17.4. CERENOVUS

17.4.1. Company Details

17.4.2. Company Overview

17.4.3. Product Offerings

17.4.4. Key Developments

17.4.5. Financial Analysis

17.4.6. SWOT Analysis

17.4.7. Business Strategies

17.5. Medtronic

17.5.1. Company Details

17.5.2. Company Overview

17.5.3. Product Offerings

17.5.4. Key Developments

17.5.5. Financial Analysis

17.5.6. SWOT Analysis

17.5.7. Business Strategies

17.6. MicroPort Scientific Corporation

17.6.1. Company Details

17.6.2. Company Overview

17.6.3. Product Offerings

17.6.4. Key Developments

17.6.5. Financial Analysis

17.6.6. SWOT Analysis

17.6.7. Business Strategies

17.7. Stryker

17.7.1. Company Details

17.7.2. Company Overview

17.7.3. Product Offerings

17.7.4. Key Developments

17.7.5. Financial Analysis

17.7.6. SWOT Analysis

17.7.7. Business Strategies

17.8. Terumo Corporation

17.8.1. Company Details

17.8.2. Company Overview

17.8.3. Product Offerings

17.8.4. Key Developments

17.8.5. Financial Analysis

17.8.6. SWOT Analysis

17.8.7. Business Strategies

17.9. Other Market Participants

18. Key Findings

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.

Prominent participants in our primary research process include:

Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

Reuters
Factiva
Bloomberg
One Source
Hoovers

Research Methodology

Key Inclusions

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Single users $4600

Multi users $8200

Global users $9100

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com